Top Markets
#1 MowCat MowCat +49.00%
#2 Velvet Velvet +28.16%
#3 Derive Derive +22.75%
#4 Audiera Audiera +19.65%
#5 Geodnet Geodnet +16.26%
#6 Biconomy Biconomy +16.21%
#7 aPriori aPriori +15.56%
#8 Quack AI Quack AI +14.82%
#9 Cross Cross +13.93%
#10 The Bitcoin Bull The Bitcoin Bull +10.01%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Tissue Repair Ltd Tissue Repair Ltd

Tissue Repair Ltd

TRP
Clasificación en acciones #35634
Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical... Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
Precio por acción
$0.05994921
Última sincronización: 2026-08-13
Capitalización bursátil
$3.62M
Cambio (1 día)
-1.16%
Cambio (1 año)
-66.49%
País
AU
Comercio Tissue Repair Ltd (TRP)

Categoría

Healthcare
Ingresos de Tissue Repair Ltd (TRP)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Tissue Repair Ltd, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Tissue Repair Ltd desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE